ScinoPharm Taiwan, Ltd. (TPE:1789)
17.25
+0.60 (3.60%)
Aug 14, 2025, 1:35 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
ScinoPharm Taiwan | 3.13B | Log In | Log In | Log In | Log In | Upgrade |
ScinoPharm Taiwan Growth | 5.26% | Log In | Log In | Log In | Log In | Upgrade |
Changshu ScinoParm | 275.04M | Log In | Log In | Log In | Log In | Upgrade |
Changshu ScinoParm Growth | 55.67% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.78M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -95.09% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.78M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -95.09% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Other | 36.07M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.47% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 1.42B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 20.62% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 675.06M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | -2.19% | Log In | Log In | Log In | Log In | Upgrade |
India | 529.29M | Log In | Log In | Log In | Log In | Upgrade |
India Growth | 0.77% | Log In | Log In | Log In | Log In | Upgrade |
United States | 403.66M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -17.72% | Log In | Log In | Log In | Log In | Upgrade |
Taiwan | 346.88M | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 27.76% | Log In | Log In | Log In | Log In | Upgrade |
Other | 36.07M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.47% | Log In | Log In | Log In | Log In | Upgrade |